The Dubai Health Authority signed today an agreement with Vertis Trading LLC for introducing the capsule endoscopy procedure in Rashid Hospital.
The new facility will facilitate better diagnostic services with regard to digestive diseases disorders and thus will benefit patients by providing a more detailed and accurate diagnosis of their condition.
Mr Gamal Farid Nagi, Director of Finance at the DHA and Mr Thomas Mathew, Managing Director of Virtus Trading LLC signed the agreement at the DHA headquarters, in the presence of senior DHA members including Mr Walid Jamal Al Sawalhi, Director of Purchasing and Contracts Section, Ibtesam Ibrahim Bastaki, Director of Business Development and Projects Department, Hospital Services Sector, Dr El Hassan, Gastroenterologist and Head of the Digestive Diseases Unit at Rashid Hospital and Dr Ali Hussain Al Hamadi, Head of Business Development and Revenue Section, Hospital Services Sector.
Dr El Hassan, Gastroenterologist and Head of the Digestive Diseases Unit at Rashid Hospital highlighted that the benefit of this procedure is that it provides complete imaging for areas which were earlier not easily accessible by conventional endoscopy such as the small intestine.
With the signing of this contract, the digestive disease unit at the Rashid Hospital will get access to these capsules and the software required for accurate imaging. Furthermore, the company will also send physicians from the endoscopy unit at Rashid Hospital abroad to train them on how to apply this new procedure.
The procedure will be introduced within two to three weeks, whereby a patient who requires imaging will be asked to swallow a capsule, which is fitted with a small camera that captures images of small intestine. Later with the help of specialised software the images are displayed onto a screen and analysed to diagnose any abnormalities.
The new state-of-the-art procedure is aimed to benefit patients by providing through and accurate diagnosis of their condition.
-End-
About The DHA:
The Dubai Health Authority (DHA) was created in June 2007, by Law 13 issued by His Highness Sheikh Mohammad Bin Rashid Al Maktoum, UAE Vice President, Prime Minister and Ruler of Dubai As the strategic health authority for the Emirate of Dubai, the DHA is empowered to set policies and strategies for health and to assure the application of those health policies and strategies. His Excellency Qadhi Saeed Al Murooshid is the Director General of the Dubai Health Authority (DHA).
The DHA's aim in Dubai is to provide an accessible, effective and integrated healthcare system, protect public health and improve the quality of life within the Emirate. This is a direct translation of the objectives of the Dubai Strategic Plan 2015 launched by His Highness Sheikh Mohammad Bin Rashid Al Maktoum. Keeping the strategic plan in mind, the DHA's mission is to ensure access to health services, maintain and improve the quality of these services, improve the health status of nationals, residents and visitors and oversee a dynamic, efficient and innovative health sector.
In addition to overseeing the health sector for the Emirate of Dubai, the DHA also focuses on providing services through DHA healthcare facilities including hospitals (Al Wasl, Dubai and Rashid), specialty centres (e.g. the Joslin Diabetes Center) and DHA primary health centres spread throughout the Emirate of Dubai.
The main pillars of service delivery at DHA health facilities are quality, efficiency, patients and staff. It is our aim to maintain and/or improve the quality and efficiency of DHA health services. An important aspect of the service delivery strategy is to focus on patients, their needs and satisfaction as well as as well as attract, retain, nurture and support outstanding staff.
For more information, please contact
Kamakshi Gupta
Communications Analyst
Institutional Marketing and Communications Department, DHA
Email: klgupta@dha.gov.ae
Tel: 009714- 2197455
© Press Release 2010
